Global Cystic Fibrosis (CF) Therapeutics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Pancreatic enzyme supplements
  • 1.2.3 Mucolytics
  • 1.2.4 Bronchodilators
  • 1.2.5 CFTR modulators
• 1.3 Market by Application
  • 1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Oral drugs
  • 1.3.3 Inhaled drugs
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2017-2028)
• 2.2 Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
  • 2.2.1 Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2017-2022)
  • 2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2023-2028)
• 2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
  • 2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
  • 2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
  • 2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
  • 2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
  • 3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2017-2022)
  • 3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2017-2022)
• 3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
• 3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
  • 3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2021
• 3.5 Cystic Fibrosis (CF) Therapeutics Key Players Head office and Area Served
• 3.6 Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
• 3.7 Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type

• 4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2017-2022)
• 4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2023-2028)

5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application

• 5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2017-2022)
• 5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
• 6.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type
  • 6.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
  • 6.2.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
  • 6.2.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
• 6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application
  • 6.3.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
  • 6.3.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
  • 6.3.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
• 6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country
  • 6.4.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
  • 6.4.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
• 7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type
  • 7.2.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
  • 7.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
  • 7.2.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
• 7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application
  • 7.3.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
  • 7.3.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
  • 7.3.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
• 7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country
  • 7.4.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
  • 7.4.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
• 8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type
  • 8.2.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application
  • 8.3.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region
  • 8.4.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
• 9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type
  • 9.2.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
  • 9.2.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
  • 9.2.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
• 9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application
  • 9.3.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
  • 9.3.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
  • 9.3.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
• 9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country
  • 9.4.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
  • 9.4.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
• 10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type
  • 10.2.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application
  • 10.3.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country
  • 10.4.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Vertex Pharmaceuticalsorporated
  • 11.1.1 Vertex Pharmaceuticalsorporated Company Details
  • 11.1.2 Vertex Pharmaceuticalsorporated Business Overview
  • 11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.1.5 Vertex Pharmaceuticalsorporated Recent Developments
• 11.2 Gilead
  • 11.2.1 Gilead Company Details
  • 11.2.2 Gilead Business Overview
  • 11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.2.5 Gilead Recent Developments
• 11.3 AbbVie,
  • 11.3.1 AbbVie, Company Details
  • 11.3.2 AbbVie, Business Overview
  • 11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.3.5 AbbVie, Recent Developments
• 11.4 Novartis AG
  • 11.4.1 Novartis AG Company Details
  • 11.4.2 Novartis AG Business Overview
  • 11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.4.5 Novartis AG Recent Developments
• 11.5 F. Hoffmann-La Roche Ltd
  • 11.5.1 F. Hoffmann-La Roche Ltd Company Details
  • 11.5.2 F. Hoffmann-La Roche Ltd Business Overview
  • 11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.5.5 F. Hoffmann-La Roche Ltd Recent Developments
• 11.6 Alaxia
  • 11.6.1 Alaxia Company Details
  • 11.6.2 Alaxia Business Overview
  • 11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.6.5 Alaxia Recent Developments
• 11.7 Merck & Co.
  • 11.7.1 Merck & Co. Company Details
  • 11.7.2 Merck & Co. Business Overview
  • 11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.7.5 Merck & Co. Recent Developments
• 11.8 AIT (Advanced Inhalation Therapies)
  • 11.8.1 AIT (Advanced Inhalation Therapies) Company Details
  • 11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
  • 11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.8.5 AIT (Advanced Inhalation Therapies) Recent Developments
• 11.9 ALLERGAN
  • 11.9.1 ALLERGAN Company Details
  • 11.9.2 ALLERGAN Business Overview
  • 11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.9.5 ALLERGAN Recent Developments
• 11.10 AstraZeneca
  • 11.10.1 AstraZeneca Company Details
  • 11.10.2 AstraZeneca Business Overview
  • 11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.10.5 AstraZeneca Recent Developments
• 11.11 Teva Pharmaceutical Industries Ltd
  • 11.11.1 Teva Pharmaceutical Industries Ltd Company Details
  • 11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
  • 11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments
• 11.12 Alcresta
  • 11.12.1 Alcresta Company Details
  • 11.12.2 Alcresta Business Overview
  • 11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
  • 11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
  • 11.12.5 Alcresta Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Pancreatic enzyme supplements
• Table 3. Key Players of Mucolytics
• Table 4. Key Players of Bronchodilators
• Table 5. Key Players of CFTR modulators
• Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2017-2022)
• Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2023-2028)
• Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
• Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
• Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
• Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
• Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
• Table 17. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Players (2017-2022)
• Table 18. Global Top Cystic Fibrosis (CF) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2021)
• Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2021
• Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
• Table 21. Key Players Headquarters and Area Served
• Table 22. Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
• Table 23. Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2017-2022)
• Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2023-2028)
• Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Application (2017-2022)
• Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Application (2023-2028)
• Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 36. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 37. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 38. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 39. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 40. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 41. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 42. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 43. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 44. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
• Table 51. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 52. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 53. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 54. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 55. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 56. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 63. Vertex Pharmaceuticalsorporated Company Details
• Table 64. Vertex Pharmaceuticalsorporated Business Overview
• Table 65. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
• Table 66. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 67. Vertex Pharmaceuticalsorporated Recent Developments
• Table 68. Gilead Company Details
• Table 69. Gilead Business Overview
• Table 70. Gilead Cystic Fibrosis (CF) Therapeutics Product
• Table 71. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 72. Gilead Recent Developments
• Table 73. AbbVie, Company Details
• Table 74. AbbVie, Business Overview
• Table 75. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
• Table 76. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 77. AbbVie, Recent Developments
• Table 78. Novartis AG Company Details
• Table 79. Novartis AG Business Overview
• Table 80. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
• Table 81. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 82. Novartis AG Recent Developments
• Table 83. F. Hoffmann-La Roche Ltd Company Details
• Table 84. F. Hoffmann-La Roche Ltd Business Overview
• Table 85. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
• Table 86. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 87. F. Hoffmann-La Roche Ltd Recent Developments
• Table 88. Alaxia Company Details
• Table 89. Alaxia Business Overview
• Table 90. Alaxia Cystic Fibrosis (CF) Therapeutics Product
• Table 91. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 92. Alaxia Recent Developments
• Table 93. Merck & Co. Company Details
• Table 94. Merck & Co. Business Overview
• Table 95. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
• Table 96. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 97. Merck & Co. Recent Developments
• Table 98. AIT (Advanced Inhalation Therapies) Company Details
• Table 99. AIT (Advanced Inhalation Therapies) Business Overview
• Table 100. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
• Table 101. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 102. AIT (Advanced Inhalation Therapies) Recent Developments
• Table 103. ALLERGAN Company Details
• Table 104. ALLERGAN Business Overview
• Table 105. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
• Table 106. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 107. ALLERGAN Recent Developments
• Table 108. AstraZeneca Company Details
• Table 109. AstraZeneca Business Overview
• Table 110. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
• Table 111. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 112. AstraZeneca Recent Developments
• Table 113. Teva Pharmaceutical Industries Ltd Company Details
• Table 114. Teva Pharmaceutical Industries Ltd Business Overview
• Table 115. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
• Table 116. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 117. Teva Pharmaceutical Industries Ltd Recent Developments
• Table 118. Alcresta Company Details
• Table 119. Alcresta Business Overview
• Table 120. Alcresta Cystic Fibrosis (CF) Therapeutics Product
• Table 121. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
• Table 122. Alcresta Recent Developments
• Table 123. Research Programs/Design for This Report
• Table 124. Key Data Information from Secondary Sources
• Table 125. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2021 VS 2028
• Figure 2. Pancreatic enzyme supplements Features
• Figure 3. Mucolytics Features
• Figure 4. Bronchodilators Features
• Figure 5. CFTR modulators Features
• Figure 6. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2021 VS 2028
• Figure 7. Oral drugs Case Studies
• Figure 8. Inhaled drugs Case Studies
• Figure 9. Cystic Fibrosis (CF) Therapeutics Report Years Considered
• Figure 10. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 11. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2021 VS 2028
• Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2021
• Figure 14. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2021)
• Figure 15. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2021
• Figure 16. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 17. North America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 18. North America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
• Figure 20. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 24. Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 25. Europe Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
• Figure 26. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 33. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 34. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 35. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Share by Region (2017-2028)
• Figure 36. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 45. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
• Figure 46. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 50. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 51. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
• Figure 52. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. UAE Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 56. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 57. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 58. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 60. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 61. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 62. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 63. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 64. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 65. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 66. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
• Figure 67. Bottom-up and Top-down Approaches for This Report
• Figure 68. Data Triangulation
• Figure 69. Key Executives Interviewed